Far Cortical Locking Versus Standard Constructs for Distal Femur Fractures

NCT ID: NCT01766648

Last Updated: 2022-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

167 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if Far Cortical Locking screws increase fracture healing rates at 3 months in Closed Distal Femur Fractures in adults when compared to Standard screw constructs.

Fracture healing at 3 months will be assessed via radiographic and clinical assessment of the fracture.

Null Hypothesis: There will be no difference in fracture healing at 3 months post-fixation between subjects treated with far cortical locking screw or standard screw fixation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multicentre randomized controlled trial with a sample size of 138 subjects.

Primary Outcome is fracture healing at 3 months via radiographic and and clinical assessment.

Radiographic healing will be defined as bridging of one or more cortices as seen on x-ray. Radiographic assessment will be centrally adjudicated by a committee of three study investigators.

Clinical healing will be assessed using the Function Index for Trauma (FIX-IT).

Secondary outcome measurements will include patient-reported quality of life and CT quantification of fracture callus volume.

Quality of life will be measured with the Short-Form 36 Version 2 (SF-36) instrument at all follow-up intervals.

A CT scan of the fracture site will be performed at the 3 month follow-up. Using a quantitative protocol the volume of callus will be measured and the extent of cortical bridging will be assessed.

Additional secondary outcomes include radiographic and clinical healing, as well as patient-important complications. These will include adverse events, delayed union (\>6 months), non union (failure for fracture healing to progress on serial x-rays between 6 and 9 months), malalignment (\>5 degrees), hardware failure, infection, and reoperation. Information surrounding the type of complication, duration, management and/or treatment of all complications will be recorded

A Data Safety Monitoring Board will be established to independently monitor trial data.

Specific inclusion criteria:

* Men or women ages 18 years or older
* Displaced distal femur fracture (OTA 33A or 33C) as seen in radiographs
* Planned treatment using a distal femur locking plate
* Ability to read and speak English or availability of translator willing to assist with completion of study forms
* Fractures \< 14 days post injury
* Provision of informed consent

Specific exclusion criteria:

* Open distal femur fracture requiring flap or vascular repair (grade 3b or 3c)
* Planned fixation strategy includes interfragmentary lag fixation of non-articular fractures
* Active local infection
* Limited life expectancy due to significant medical co-morbidity or medical contraindication to surgery
* Inability to comply with rehabilitation or form completion
* Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e. patients with no fixed address, patients not mentally competent to give consent, etc.)
* Non-ambulatory patients
* Lack of bone substance or poor bone quality which, in the surgeon's judgment, makes locked plate fixation impossible
* Periprosthetic fractures
* Any concomitant lower-extremity injury that requires non-weight-bearing beyond 6 weeks post-operative
* Addition of bone graft, bone graft substitute or BMP
* Pregnant women

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Distal Femur Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Far Cortical Locking screw fixation

Far Cortical Locking screw fixation

Group Type EXPERIMENTAL

Far Cortical locking screw fixation

Intervention Type DEVICE

Standard screw fixation

Standard screw fixation

Standard screw fixation

Group Type ACTIVE_COMPARATOR

Standard screw fixation

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Far Cortical locking screw fixation

Standard screw fixation

Intervention Type DEVICE

Standard screw fixation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women ages 18 years or older
* Displaced distal femur fracture (OTA 33A or 33C) as seen in radiographs
* Planned treatment using a distal femur locking plate
* Ability to read and speak English or availability of translator willing to assist with completion of study forms
* Fractures \< 14 days post injury
* Provision of informed consent

Exclusion Criteria

* Open distal femur fracture requiring flap or vascular repair (grade 3b or 3c)
* Planned fixation strategy includes interfragmentary lag fixation of non-articular fractures
* Active local infection
* Limited life expectancy due to significant medical co-morbidity or medical contraindication to surgery
* Inability to comply with rehabilitation or form completion
* Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e. patients with no fixed address, patients not mentally competent to give consent, etc.)
* Non-ambulatory patients
* Lack of bone substance or poor bone quality which, in the surgeon's judgment, makes locked plate fixation impossible
* Periprosthetic fractures
* Any concomitant lower-extremity injury that requires non-weight-bearing beyond 6 weeks post-operative
* Addition of bone graft, bone graft substitute or BMP
* Pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kelly A. Lefaivre

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kelly Lefaivre, MD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia, Vancouver Coastal Health Authority

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vancouver General Hospital

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Claireaux HA, Searle HKC, Parsons NR, Griffin XL. Interventions for treating fractures of the distal femur in adults. Cochrane Database Syst Rev. 2022 Oct 5;10(10):CD010606. doi: 10.1002/14651858.CD010606.pub3.

Reference Type DERIVED
PMID: 36197809 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H12-03489

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.